Oncternal Therapeutics Inc Net Asset Quality Index
Oncternal Therapeutics Inc net asset quality index. Oncternal Therapeutics Inc (ONCT) has a Net Asset Quality Index of 58.6% as of September 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $15.60 Million minus total liabilities of $6.45 Million yields net assets of $9.15 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Oncternal Therapeutics Inc for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Oncternal Therapeutics Inc (1999–2023)
Net asset quality index of Oncternal Therapeutics Inc from 1999 to 2023. This chart shows how Oncternal Therapeutics Inc's Net Asset Quality Index has evolved across 25 annual periods from 1999 to 2023. As of September 2024, the index stands at 58.6%, representing net assets of $9.15 Million against total assets of $15.60 Million USD. Check ONCT PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Oncternal Therapeutics Inc Net Asset Quality Index by Year (1999–2023)
Oncternal Therapeutics Inc net asset quality index by year from 1999 to 2023. The table below presents the year-by-year Net Asset Quality Index for Oncternal Therapeutics Inc from 1999 to 2023, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Oncternal Therapeutics Inc market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 81.8% | $30.05 Million | $36.73 Million | $6.68 Million | ▼ -7.0 pp |
| 2022 | 88.8% | $60.97 Million | $68.65 Million | $7.68 Million | ▼ -5.4 pp |
| 2021 | 94.2% | $88.12 Million | $93.58 Million | $5.46 Million | ▼ -0.9 pp |
| 2020 | 95.1% | $112.95 Million | $118.81 Million | $5.86 Million | ▲ +29.2 pp |
| 2019 | 65.8% | $14.31 Million | $21.74 Million | $7.43 Million | ▼ -17.5 pp |
| 2018 | 83.4% | $26.11 Million | $31.32 Million | $5.21 Million | ▲ +0.6 pp |
| 2017 | 82.8% | $38.26 Million | $46.24 Million | $7.97 Million | ▲ +1.6 pp |
| 2016 | 81.2% | $19.89 Million | $24.50 Million | $4.61 Million | ▲ +75.4 pp |
| 2015 | 5.8% | $1.86 Million | $32.03 Million | $30.17 Million | ▼ -29.4 pp |
| 2014 | 35.2% | $17.83 Million | $50.65 Million | $32.82 Million | ▼ -33.3 pp |
| 2013 | 68.5% | $10.68 Million | $15.61 Million | $4.92 Million | ▼ -14.1 pp |
| 2012 | 82.6% | $47.70 Million | $57.77 Million | $10.07 Million | ▼ -9.4 pp |
| 2011 | 91.9% | $71.87 Million | $78.18 Million | $6.31 Million | ▲ +11.4 pp |
| 2010 | 80.5% | $51.73 Million | $64.25 Million | $12.52 Million | ▲ +95.7 pp |
| 2009 | -15.2% | $-8.75 Million | $57.72 Million | $66.47 Million | ▼ -44.8 pp |
| 2008 | 29.6% | $32.02 Million | $108.11 Million | $76.09 Million | ▼ -19.8 pp |
| 2007 | 49.4% | $78.92 Million | $159.73 Million | $80.81 Million | ▼ -25.7 pp |
| 2006 | 75.1% | $97.05 Million | $129.25 Million | $32.21 Million | ▼ -13.8 pp |
| 2005 | 88.9% | $73.58 Million | $82.81 Million | $9.23 Million | ▲ +1.4 pp |
| 2004 | 87.4% | $63.91 Million | $73.08 Million | $9.17 Million | ▲ +955.3 pp |
| 2003 | -867.9% | $-150.23 Million | $17.31 Million | $167.54 Million | ▼ -316.5 pp |
| 2002 | -551.4% | $-55.31 Million | $10.03 Million | $65.34 Million | ▼ -214.6 pp |
| 2001 | -336.8% | $-34.08 Million | $10.12 Million | $44.19 Million | ▲ +449.4 pp |
| 2000 | -786.2% | $-25.16 Million | $3.20 Million | $28.37 Million | ▼ -787.4 pp |
| 1999 | 1.3% | $21.00K | $1.68 Million | $1.66 Million | — |